Dev Information Technology Limited — Updates, 02-07-2025: Press Release

Dev IT has announced a board meeting to consider the financial results for the quarter and half-year. The company secured a major IT deal worth ₹4.4 Cr from Alivus Lifesciences, including ₹3.6 Cr for Microsoft Select Plus licenses (advisory role) and ₹0.8 Cr for enterprise software solutions like Microsoft, Zoho, Adobe, and TeamViewer. This strengthens Dev IT’s footprint in pharma IT services and highlights its capability in delivering integrated, scalable digital transformation solutions. In FY25, Dev IT reported total income of ₹183.91 Cr, EBITDA of ₹23.72 Cr, and net profit of ₹14.78 Cr.